Analysis
Navigate the transition to value-based care in life sciences
A framework to help assess the value of MedTech products and offerings
Discover a framework to help life sciences organizations thrive in the shift to value-based care.
People
Glenn Snyder
Medical Technology Segment Leader
Glenn leads Deloitte LLP's Medical Technology practice with more than 25 years of experience in medical technology, biotech, and specialty pharmaceuticals. He helps clients grow through organic and inorganic means by entering new geographic markets, and expanding into new product/service areas. Glenn also helps clients improve brand/commercial effectiveness by articulating product economic value, applying innovative pricing, updating the commercial model, and rationalizing distribution networks.
Related content
Analysis
Reinvigorating medtech innovation
Venture capital investments in the medtech industry have declined. Find out how this may impact new innovations and life-saving treatments for patients.
Analysis
Next-generation “smart” MedTech devices
Smart, connected medical devices are now technologically/economically feasible. How might an increasingly intelligent future reshape the MedTech industry?